Healthcare provider profile · identity verified

Mohammed Yousufuddin, M.D.

Internal Medicine · BROOKLYN, NY · NPI 1033137351

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	575	164
Metformin Hcl	Metformin Hcl	426	106
Amlodipine Besylate	Amlodipine Besylate	397	109
Losartan Potassium	Losartan Potassium	312	89
Glimepiride	Glimepiride	267	66
Tamsulosin Hcl	Tamsulosin Hcl	261	75
Simvastatin	Simvastatin	258	63
Omeprazole	Omeprazole	254	76
Metoprolol Succinate	Metoprolol Succinate	236	69
Alcohol Prep Pads	Alcohol Antiseptic Pads	229	82
Pioglitazone Hcl	Pioglitazone Hcl	229	56
Jardiance	Empagliflozin	215	44
Janumet	Sitagliptin Phos/Metformin Hcl	210	48
Albuterol Sulfate Hfa	Albuterol Sulfate	206	59
Lisinopril	Lisinopril	183	54
Gabapentin	Gabapentin	171	48
Levothyroxine Sodium	Levothyroxine Sodium	157	36
Pantoprazole Sodium	Pantoprazole Sodium	154	53
Rosuvastatin Calcium	Rosuvastatin Calcium	151	41
Trulicity	Dulaglutide	146	26
Enalapril Maleate	Enalapril Maleate	144	29
Atenolol	Atenolol	141	27
Vascepa	Icosapent Ethyl	137	38
Alendronate Sodium	Alendronate Sodium	120	37
Montelukast Sodium	Montelukast Sodium	115	35
Januvia	Sitagliptin Phosphate	113	24
Valsartan	Valsartan	112	33
Clopidogrel	Clopidogrel Bisulfate	107	31
Farxiga	Dapagliflozin Propanediol	102	28
Easy Touch Alcohol Prep Pads	Alcohol Antiseptic Pads	99	37
Ultra-Fine Nano Pen Needle	Pen Needle, Diabetic	95	27
Zolpidem Tartrate	Zolpidem Tartrate	93	24
Fenofibrate	Fenofibrate	89	28
Ammonium Lactate	Ammonium Lactate	88	28
Linzess	Linaclotide	87	18
Furosemide	Furosemide	86	25
Ozempic	Semaglutide	83	19
Folic Acid	Folic Acid	78	20
Esomeprazole Magnesium	Esomeprazole Magnesium	75	21
Novolog Flexpen	Insulin Aspart	75	20
Fluticasone Propionate	Fluticasone Propionate	74	28
Carvedilol	Carvedilol	73	23
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	71	19
Diclofenac Sodium	Diclofenac Sodium	71	31
Vitamin D2	Ergocalciferol (Vitamin D2)	71	32
Finasteride	Finasteride	68	22
Janumet Xr	Sitagliptin Phos/Metformin Hcl	64	20
Celecoxib	Celecoxib	63	40
Breo Ellipta	Fluticasone/Vilanterol	62	18
Tradjenta	Linagliptin	62	14
Ropinirole Hcl	Ropinirole Hcl	61	15
Metoprolol Tartrate	Metoprolol Tartrate	59	20
Hydrochlorothiazide	Hydrochlorothiazide	58	15
Ezetimibe	Ezetimibe	56	18
Pravastatin Sodium	Pravastatin Sodium	56	15
Irbesartan	Irbesartan	55	13
Famotidine	Famotidine	54	17
Alcohol Pads	Alcohol Antiseptic Pads	53	22
Clotrimazole-Betamethasone	Clotrimazole/Betamethasone Dip	53	21
Nifedipine Er	Nifedipine	53	14
Tramadol Hcl	Tramadol Hcl	51	12
Baclofen	Baclofen	48	28
Valsartan-Hydrochlorothiazide	Valsartan/Hydrochlorothiazide	48	12
Eliquis	Apixaban	46	14
Mounjaro	Tirzepatide	46	12
Spironolactone	Spironolactone	45	11
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	43	11
Azithromycin	Azithromycin	42	38
Brilinta	Ticagrelor	42	suppressed
Myrbetriq	Mirabegron	42	13
Alcohol Swab	Alcohol Antiseptic Pads	40	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	40	11
Novolog Mix 70-30 Flexpen	Insulin Aspart Prot/Insuln Asp	39	suppressed
Alprazolam	Alprazolam	38	11
Cyanocobalamin Injection	Cyanocobalamin (Vitamin B-12)	38	13
Escitalopram Oxalate	Escitalopram Oxalate	38	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	38	suppressed
Ibuprofen	Ibuprofen	36	17
Allopurinol	Allopurinol	35	suppressed
Doxazosin Mesylate	Doxazosin Mesylate	35	suppressed
Prednisone	Prednisone	35	24
Fenofibrate	Fenofibrate,micronized	34	12
Amoxicillin	Amoxicillin	32	29
Budesonide-Formoterol Fumarate	Budesonide/Formoterol Fumarate	32	15
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	32	11
Single Use Swab	Alcohol Antiseptic Pads	32	17
Triamcinolone Acetonide	Triamcinolone Acetonide	31	16
Alcohol Swabs	Alcohol Antiseptic Pads	30	11
Comfort Ez Pen Needle	Pen Needle, Diabetic	30	11
Ketoconazole	Ketoconazole	30	13
Lactulose	Lactulose	26	suppressed
Latanoprost	Latanoprost	26	suppressed
Clotrimazole	Clotrimazole	25	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	24	15
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	24	suppressed
Paroxetine Hcl	Paroxetine Hcl	24	suppressed
Ultra-Fine Mini Pen Needle	Pen Needle, Diabetic	24	suppressed
Pregabalin	Pregabalin	23	suppressed
Betamethasone Dipropionate	Betamethasone Dipropionate	22	13
Meclizine Hcl	Meclizine Hcl	22	12
Xarelto	Rivaroxaban	22	suppressed
Toujeo Solostar	Insulin Glargine,hum.Rec.Anlog	21	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	20	17
Entresto	Sacubitril/Valsartan	20	suppressed
Jentadueto	Linagliptin/Metformin Hcl	19	suppressed
Labetalol Hcl	Labetalol Hcl	19	suppressed
Ranolazine Er	Ranolazine	19	suppressed
Betamethasone Diprop Augmented	Betamethasone/Propylene Glyc	18	suppressed
Buspirone Hcl	Buspirone Hcl	17	suppressed
Candesartan Cilexetil	Candesartan Cilexetil	17	suppressed
Metformin Hcl Er	Metformin Hcl	17	suppressed
Restasis	Cyclosporine	17	suppressed
Symbicort	Budesonide/Formoterol Fumarate	16	11
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Gemfibrozil	Gemfibrozil	15	suppressed
Hydralazine Hcl	Hydralazine Hcl	15	suppressed
Kerendia	Finerenone	15	suppressed
Pro Comfort Alcohol Pads	Alcohol Antiseptic Pads	15	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	14	suppressed
Dutasteride	Dutasteride	14	suppressed
Glipizide Er	Glipizide	14	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	14	suppressed
Pioglitazone-Metformin	Pioglitazone Hcl/Metformin Hcl	14	suppressed
Divalproex Sodium	Divalproex Sodium	13	suppressed
Neomycin-Polymyxin-Hc	Neomycin/Polymyxin B/Hydrocort	13	suppressed
Admelog Solostar	Insulin Lispro	12	suppressed
Clobetasol Propionate	Clobetasol Propionate	12	suppressed
Clonazepam	Clonazepam	12	suppressed
Donepezil Hcl	Donepezil Hcl	12	suppressed
Hydrocortisone	Hydrocortisone	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Prasugrel Hcl	Prasugrel Hcl	12	suppressed
Ramipril	Ramipril	12	suppressed
Ultra-Fine Short Pen Needle	Pen Needle, Diabetic	12	suppressed
Ventolin Hfa	Albuterol Sulfate	12	suppressed
Bumetanide	Bumetanide	11	suppressed
Creon	Lipase/Protease/Amylase	11	suppressed
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	11	suppressed
Irbesartan-Hydrochlorothiazide	Irbesartan/Hydrochlorothiazide	11	suppressed
Meloxicam	Meloxicam	11	suppressed
Metolazone	Metolazone	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Trazodone Hcl	Trazodone Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error